Anxiety states and sleep disorders are commonproblems
World Sleeping Day
3.21
Effects of Sedative-Hypnotics
Anti-anxiety
Sedation-Hypnosis
Anti-convulsant effect
Antiepileptic
Anesthesia
Respiratory paralysis (death)
Sedative-Hypnotics
Benzodiazepines (BZ/BDZ/BZD)
Barbiturates
Others
Benzodiazepines (BZ/BDZ/BZD)
Short-acting (t1/2<6 h)
Intermediate-acting (t1/2= 6~20 h)
Long-acting (t1/2>20 h)
Barbiturates
Long-acting
Intermediate-acting
Short-acting
Super short-acting
Pharmacokinetics
Absorption: po; im; iv
Distribution: Enter CNS, Cross placental barrier, Enter breast milk
Biotransformation: Liver drug metabolizing, Enzyme inducer: Barbiturates
Excretion: Kidney
Mechanism of Benzodiazepines
Chloride ion channel, GABA-BZ receptor-chloride ion channel complex
Benzodiazepines prolong the opening time of the chloride channel, enhancing the inhibitory effect of GABA
Barbiturates bind to the barbiturate binding site, prolonging the opening time of the chloride channel to exert an inhibitory effect
Pharmacological effects
Antianxiety
Sedation & Hypnosis
Anesthesia
Anticonvulsant effects and antiepileptic effects
Muscle Relaxation
Respiratory and cardiovascular depression
Tolerance and dependence
Antianxiety
Smaller than hypnotic dose, relieve anxiety, decrementaling psychomotor and cognitive functions, anterograde amnesic
Sedation & Hypnosis
Two phases of sleep: REM sleep and NREM sleep, decrease the latency of sleep onset, prolong duration of NREM sleep, shorten duration of REM sleep
Anesthesia
High lipid solubility, rapid tissue redistribution, use for induction of the anesthetic state
Anticonvulsant effects and antiepileptic effects
Inhibit development and spread of epileptiform activity, without marked CNS depression
Muscle Relaxation
Inhibit polysynaptic reflexes, inhibit internuncial transmission, depress transmission at the skeletal neuromuscular junction at high doses
Respiratory and cardiovascular depression
In patients with pulmonary disease, overdose, depressing the medullary respiratory and cardiovascular center
Tolerance and dependence
Mechanism of tolerance: Barbiturates - increased drug metabolism, changed responsiveness of CNS; Benzodiazepines - down-regulation of brain BZ receptors
Clinical Uses
Anxiety states: first choice drug is BDZ
Sleep disorders: first choice drug is BDZ
Anticonvulsant and antiepileptic
Muscle relaxant
Inducing anesthesia
Compared with Barbiturates, Benzodiazepines have a higher therapeutic index, less liver enzyme induction effect, less adverse effects, and less rebound reaction
Newer drugs for sleep disorders like Zolpidem and Zaleplon have less change in sleep patterns, less rebound insomnia, and less risk of developing tolerance and dependence
Anticonvulsant uses
Tetanus
Eclampsia
Intoxication and fever (children)
Antiepileptic uses
Diazepam for status epilepticus (iv)
Phenobarbital for generalized tonic-clonic seizure (grand mal)
Muscle relaxant uses
Reduces muscle rigidity induced by CNS damage, relieves muscle spasm induced by joint pathological changes
Inducing anesthesia
Thiopental, iv
Adverse Effects
After effect ('hang-over' effect)
Rebound reaction
Tolerance and dependence
Acute overdose poisoning
After effect ('hang-over' effect)
Dizziness, drowsiness, dysphoria, fatigue, impaired judgment, and diminished motor skills, more common with drugs with long t1/2
Rebound reaction
Insomnia, anxiety, tremor, rebounded prolonged REM sleep with nightmare
Tolerance and dependence
Long time use, more common with Barbiturates than Benzodiazepines
Acute overdose poisoning
Severe respiratory depression, more common with Barbiturates than Benzodiazepines